Phathom Pharmaceuticals, Inc. files DEF 14A

Phathom Pharmaceuticals, Inc. will hold its 2026 Annual Meeting of Stockholders on May 19, 2026, to elect three Class I directors, ratify the appointment of Ernst & Young LLP as its independent registered public accounting firm, and approve named executive officer compensation on an advisory basis. The Board of Directors recommends voting "FOR" all proposals.